Get In Touch

Immunoprotein is a protein type with immunological activity that provides immunity against substances or pathogenic organisms. These proteins are used as analytes for different disease diagnostic assays such as CLIA, ELISA, radioimmunoassay (RIA), and immunoturbidity assay. Immunoprotein testing products are continuously fueled with innovative technologies, expanding the boundaries of the immunoprotein market. The innovations lead to widening of scope for product applications in various fields such as infectious disease testing, allergy testing, drug abuse testing, and the most prominent being oncology. Extensive research in the field of oncology has resulted in various biomarkers being profiled, which are specific to a particular type of cancer.

Increase in demand for quick and accurate disease diagnosis and rise in incidence of infectious and chronic diseases are the major factors that are likely to boost the growth of the immunoprotein market during the forecast period. Prevalence of diseases such as hepatitis, malaria, typhoid, HIV, tuberculosis, and cancer is a great concern for many countries. Majority of these diseases have high prevalence rate in underdeveloped economies; hence, demand for low cost but effective diagnostic tests is high. Diagnosis of these diseases in early stage may help in controlling infections and prevent mortalities. Immunoprotein diagnostic kits provide the best option for carrying out accurate and rapid diagnosis of the diseases. Although these tests are expensive as compared to routine microbiology assays, they provide faster and better results. However, the high cost of immunoprotein products restrains the growth of the market. In addition, low health care expenditure in underdeveloped countries and increase in awareness about medical services have led patients to seek cost-effective alternatives for diagnosis. These factors have been the major restraining forces for the growth of the immunoprotein market in developing and underdeveloped economies. 

The global immunoprotein market has been segmented based on assay type, immunoprotein type, application, and geography. In terms of assay type, the market has been categorized into chemiluminescence assay, enzyme based immunoassay, immunofluorescence assay, immunoprotein electrophoresis, immunoturbidity assay, and radioimmunoassay (RIA). Based on the immunoprotein type, the market has been segmented into complement system proteins diagnostic tests, C-reactive protein (CRP) tests, free light chain tests, immunoglobulin diagnostic tests, prealbumin tests, and haptoglobin tests. Based on application, the market has been categorized into allergy testing, endocrine testing, autoimmune disease testing, infectious disease testing, oncology testing, and toxicology testing. 

Geographically, the immunoprotein market is distributed over North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the global market for immunoprotein products due to high awareness among people along with rapid increase in demand for technologically advanced immunoprotein products. The U.S. is a major contributor of the immunoprotein market with high adoption rate of technology advanced assay systems. North America holds a substantially large market share of the global market, which is followed by Europe. Prevalence of chronic diseases along with increase in demand for immunoprotein products from developed countries such as the U.K., Germany, and France is a major factor that has helped Europe retain its position in the global market. In the Asia Pacific region, increase in demand for immunoprotein products from countries such as India, China, and Japan is expected to boost the immunoprotein market in the next few years. In addition, increased incidences of infectious diseases and growing awareness about diagnostic testing for various diseases are key factors driving the Asia Pacific market. However, affordability and lack of availability for innovative immunoprotein products are the restraining factors of the immunoprotein market in developing and undeveloped regions such as Middle East & Africa and Latin America. Despite of this, market in these regions is expected a slow growth with contribution from developing countries such as Brazil and South Africa. Latin American countries such as Mexico and Brazil are expected to have considerable potential for driving the immunoprotein market growth due to evolving medical structure and increase in awareness about diagnostic testing. 

The major players operating in this market include Abbott Laboratories, Inc., Abcam plc, DiaSorin S.p.A., Enzo Life Sciences, Inc., FUJIREBIO Diagnostics, Inc., Omega Diagnostics Group PLC, Roche Holding AG, Siemens AG, The Binding Site Group Ltd., and Thermo Fisher Scientific, Inc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Immunoprotein Market

Pre Book